Abstract
There's good news and bad news about the new H1N1 swine flu strain circling the globe. Two antiviral drugs can squelch it. But stocks are too small to protect everyone in a worst-case scenario outbreak; health officials also worry that the virus could become resistant to the drugs.
Publisher
American Association for the Advancement of Science (AAAS)
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献